Benzinga | Jul 29, 2020 11:37AM EDT

UBS Maintains Neutral on DexCom, Raises Price Target to $400

UBS analyst Matthew Taylor maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $335 to $400.